NT-proBNP as a neuroendocrine tumor biomarker: beyond heart failure
Introduction: Neuroendocrine tumors (NETs) are rare neoplasms that occur in various locations throughout the body. Despite their usually benign character, they might manifest with distant metastases. N-terminal prohormone of brain natriuretic peptide (NT-proBNP) has previously been described as a us...
| Published in: | Endocrine Connections |
|---|---|
| Main Authors: | Paweł Komarnicki, Paweł Gut, Jan Musiałkiewicz, Maja Cieślewicz, Adam Maciejewski, Prachi Patel, George Mastorakos, Marek Ruchała |
| Format: | Article |
| Language: | English |
| Published: |
Bioscientifica
2023-09-01
|
| Subjects: | |
| Online Access: | https://ec.bioscientifica.com/view/journals/ec/12/10/EC-23-0249.xml |
Similar Items
The importance of NT proBNP in hypertensive patients management for preventing heart failure
by: Irina Cuciureanu, et al.
Published: (2021-03-01)
by: Irina Cuciureanu, et al.
Published: (2021-03-01)
Performance of the Abbott Architect Immuno-Chemiluminometric NT-proBNP Assay
by: Chin-Shern Lau, et al.
Published: (2022-05-01)
by: Chin-Shern Lau, et al.
Published: (2022-05-01)
Lower NT‐proBNP plasma concentrations in Pacific peoples with heart failure
by: Andree G. Pearson, et al.
Published: (2025-08-01)
by: Andree G. Pearson, et al.
Published: (2025-08-01)
Analytical and clinical performance evaluation of a new NT-proBNP assay
by: Pingfeng Feng, et al.
Published: (2024-07-01)
by: Pingfeng Feng, et al.
Published: (2024-07-01)
Rare Case of Neuroendocrine Metastasis to the Left Ventricle
by: Said Hajouli, MD, et al.
Published: (2024-07-01)
by: Said Hajouli, MD, et al.
Published: (2024-07-01)
Prognostic Role of NT-proBNP for in-Hospital and 1-Year Mortality in Patients with Acute Exacerbations of COPD [Corrigendum]
by: Li H, et al.
Published: (2020-02-01)
by: Li H, et al.
Published: (2020-02-01)
Serum NT-proBNP levels as a marker for cardiopulmonary function in preeclampsia
by: H.M. Kim, et al.
Published: (2020-08-01)
by: H.M. Kim, et al.
Published: (2020-08-01)
Role of Serum NT-proBNP Levels in Early Prediction of Prognosis in Severe COVID-19 Pneumonia
by: Hanife Usta Atmaca, et al.
Published: (2023-11-01)
by: Hanife Usta Atmaca, et al.
Published: (2023-11-01)
Setting the optimal threshold of NT‐proBNP and BNP for the diagnosis of heart failure in patients over 75 years
by: Emmanuelle Berthelot, et al.
Published: (2024-10-01)
by: Emmanuelle Berthelot, et al.
Published: (2024-10-01)
LSPR-Based Aptasensor for Rapid Urinary Detection of NT-proBNP
by: Maria António, et al.
Published: (2023-07-01)
by: Maria António, et al.
Published: (2023-07-01)
Assessment of the Myocardial Stress Biomarker NT-proBNP in Real Clinical Practice
by: I. A. Kozlov, et al.
Published: (2023-02-01)
by: I. A. Kozlov, et al.
Published: (2023-02-01)
Prognostic and diagnostic significance of the cardiac biomarker NT-proBNP in the perioperative period of vascular surgery procedures
by: I. A. Kozlov, et al.
Published: (2023-10-01)
by: I. A. Kozlov, et al.
Published: (2023-10-01)
Electrochemical Immunosensor for NT-proBNP Detection in Artificial Human Saliva: Heart Failure Biomedical Application
by: Elkahina Ghedir, et al.
Published: (2018-12-01)
by: Elkahina Ghedir, et al.
Published: (2018-12-01)
Prognostic value of the combination of uric acid and NT-proBNP in patients with chronic heart failure
by: Gülsüm Meral Yılmaz Öztekin, et al.
Published: (2022-05-01)
by: Gülsüm Meral Yılmaz Öztekin, et al.
Published: (2022-05-01)
NT-proBNP changes predict outcomes in elderly type 2 myocardial infarction patients
by: Jinling Ma, et al.
Published: (2025-07-01)
by: Jinling Ma, et al.
Published: (2025-07-01)
Determining the role of NT-proBNP levels in diabetic patients with heart failure: A study from North India
by: Merajul H. Siddiqui, et al.
Published: (2024-02-01)
by: Merajul H. Siddiqui, et al.
Published: (2024-02-01)
Neuroendocrine Tumours: a Literature Review
by: K. V. Menshikov, et al.
Published: (2021-05-01)
by: K. V. Menshikov, et al.
Published: (2021-05-01)
State-of-the art of endoscopic semeiology of neuroendocrine tumors of the stomach
by: I. B. Perfil’yev, et al.
Published: (2011-06-01)
by: I. B. Perfil’yev, et al.
Published: (2011-06-01)
Anesthetic key points in a patient with a terminal ileum neuroendocrine tumor and a rare carcinoid left heart disease presented for non-cardiac surgery: case report
by: Kevin Van Ussel, et al.
Published: (2024-07-01)
by: Kevin Van Ussel, et al.
Published: (2024-07-01)
GALECTIN-3 AND NT-proBNP AS BIOMARKERS OF HEART FAILURE DECOMPENSATION
by: Yu. V. Dubolazova, et al.
Published: (2017-02-01)
by: Yu. V. Dubolazova, et al.
Published: (2017-02-01)
The Role of NT-proBNP Levels in the Diagnosis of Hypertensive Heart Disease
by: Angeliki Mouzarou, et al.
Published: (2025-01-01)
by: Angeliki Mouzarou, et al.
Published: (2025-01-01)
The role of NT-proBNP in screening for atrial fibrillation in hypertensive disease
by: Gina Sado, et al.
Published: (2024-12-01)
by: Gina Sado, et al.
Published: (2024-12-01)
Clinical significance of NT-proBNP as a predictive biomarker of depressive symptoms in cardiac patients
by: Syeda Humayra, et al.
Published: (2025-04-01)
by: Syeda Humayra, et al.
Published: (2025-04-01)
Successful resection of a neuroendocrine tumor in the gallbladder: a case report
by: Hideo Tomihara, et al.
Published: (2020-10-01)
by: Hideo Tomihara, et al.
Published: (2020-10-01)
Highly sensitive detection of NT-proBNP by molecular motor
by: Jie Zhang, et al.
Published: (2017-03-01)
by: Jie Zhang, et al.
Published: (2017-03-01)
Outcomes of patients with metastatic neuroendocrine lung neoplasms: typical versus atypical carcinoids
by: Hugo Tanaka, et al.
Published: (2021-10-01)
by: Hugo Tanaka, et al.
Published: (2021-10-01)
Paper Biosensor for the Detection of NT-proBNP Using Silver Nanodisks as Electrochemical Labels
by: Yi Peng, et al.
Published: (2022-06-01)
by: Yi Peng, et al.
Published: (2022-06-01)
Correlation between NT-proBNP, hsCRP and OXSR1: Clinical relevance in evaluating the prognosis of polytrauma patients
by: Costin Dumitru, et al.
Published: (2021-09-01)
by: Costin Dumitru, et al.
Published: (2021-09-01)
NT-proBNP Concentrations in the Umbilical Cord and Serum of Term Neonates: A Systematic Review and Meta-Analysis
by: Evangelos Christou, et al.
Published: (2022-06-01)
by: Evangelos Christou, et al.
Published: (2022-06-01)
The Potential Role of Salivary NT-proBNP in Heart Failure
by: Aidonis Rammos, et al.
Published: (2023-08-01)
by: Aidonis Rammos, et al.
Published: (2023-08-01)
Neuroendocrine tumors: aspects of diagnosis (literature review)
by: A.M. Kvachenyuk, et al.
Published: (2020-02-01)
by: A.M. Kvachenyuk, et al.
Published: (2020-02-01)
Longitudinal NT‐proBNP: Associations With Echocardiographic Changes and Outcomes in Heart Failure
by: Kanako Teramoto, et al.
Published: (2024-05-01)
by: Kanako Teramoto, et al.
Published: (2024-05-01)
NT-proBNP for Heart Failure Screening in Primary Care in an Eastern European Country: What We Know and Proposed Steps
by: Ioana Camelia Teleanu, et al.
Published: (2025-01-01)
by: Ioana Camelia Teleanu, et al.
Published: (2025-01-01)
Association of Cancer with Heart Failure and the Prognostic Value of NT-proBNP in Cancer Patients: Findings from the NHANES (1999–2018)
by: Qingping Zeng, et al.
Published: (2024-08-01)
by: Qingping Zeng, et al.
Published: (2024-08-01)
Clinical Value of NT-proBNP and Lactate Parameters in Infants with Congenital Heart Defects
by: Narmin Akif Azizova
Published: (2024-11-01)
by: Narmin Akif Azizova
Published: (2024-11-01)
Evaluation of in-Hospital NT-ProBNP Changes in Heart Failure Patients to Identify the Six-Month Clinical Response Following Cardiac Resynchronization Therapy
by: Gholamreza Davoodi, et al.
Published: (2014-01-01)
by: Gholamreza Davoodi, et al.
Published: (2014-01-01)
Pigmented spindle cell variant of a thymic atypical carcinoid in an octogenarian
by: Yasushi Sakamaki, et al.
Published: (2021-01-01)
by: Yasushi Sakamaki, et al.
Published: (2021-01-01)
NEUROENDOCRINE TUMOURS OF THE APPENDIX IN CHILDREN AND ADOLESCENTS
by: Neža Salobir, et al.
Published: (2024-12-01)
by: Neža Salobir, et al.
Published: (2024-12-01)
The Changes of Amino Terminal Pro B-type Natriuretic Peptide (NT-proBNP) Concentration and Left Ventricular Ejection Fraction on Doxorubicin Chemotherapy Patients
by: Telly Kamelia, et al.
Published: (2017-06-01)
by: Telly Kamelia, et al.
Published: (2017-06-01)
Dynamics of NT-proBNP and ST2 levels as markers of heart failure in patients with endogenous Cushing syndrome (hypercortisolism)
by: Raisa S. Kosharnaia, et al.
Published: (2023-01-01)
by: Raisa S. Kosharnaia, et al.
Published: (2023-01-01)
Similar Items
-
The importance of NT proBNP in hypertensive patients management for preventing heart failure
by: Irina Cuciureanu, et al.
Published: (2021-03-01) -
Performance of the Abbott Architect Immuno-Chemiluminometric NT-proBNP Assay
by: Chin-Shern Lau, et al.
Published: (2022-05-01) -
Lower NT‐proBNP plasma concentrations in Pacific peoples with heart failure
by: Andree G. Pearson, et al.
Published: (2025-08-01) -
Analytical and clinical performance evaluation of a new NT-proBNP assay
by: Pingfeng Feng, et al.
Published: (2024-07-01) -
Rare Case of Neuroendocrine Metastasis to the Left Ventricle
by: Said Hajouli, MD, et al.
Published: (2024-07-01)
